- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07655765
The Effect of Breastfeeding Education Using the Pecha Kucha Technique on Breastfeeding Self-Efficacy and Breastfeeding Success in the Early Postpartum Period: A Randomized Controlled Trial
13 de junio de 2026 actualizado por: YASEMİN AYDIN KARTAL, Saglik Bilimleri Universitesi
Breast milk is considered the most biologically appropriate source of nutrition, essential for the healthy growth and development of newborns.
Thanks to its optimal nutrients, immunological factors, and growth regulators, it not only meets nutritional needs but also protects against infections, reducing neonatal morbidity and mortality rates.
The Pecha Kucha presentation technique keeps presentations concise and dynamic, creating a fast-paced, light, and engaging experience.
It minimizes distractions and maximizes engagement.
Because there is no text to read in the Pecha Kucha technique, presenters are required to be more prepared and strive to create a coherent narrative, resulting in a flawless narrative.
Thus, the aim is to ensure the success and effectiveness of breastfeeding education with this technique, and ultimately, to promote breastfeeding education using the Pecha Kucha technique to healthcare professionals.
The population of this randomized, controlled experimental study consists of primiparous postpartum women who gave birth in the Obstetrics Department of the Physical Therapy Annex Building of the Gaziosmanpaşa Training and Research Hospital at the University of Health Sciences.
A power analysis was conducted using the G*Power package program, Version 3.1.9.4, to determine the sample size of the study.
Because no similar research was found in the literature, Cohen's medium effect size was chosen as the effect size, anticipating that tests assessing the difference between two independent groups would be used when examining the differences in variables between the control and intervention groups.
Accordingly, with 64 participants in the control group and 64 in the intervention group, a power of 80% was calculated at a significance level of 0.5 (medium) effect size and 0.05, and a minimum sample size of 128 was determined.
The study, planned using an experimental design, is planned to be conducted on two groups: an intervention and a control group.
Within the scope of the study, pretest data will be collected by administering the Breastfeeding Self-Efficacy Scale and the LATCH Breastfeeding Diagnostic and Assessment Scale, along with an introductory information form, to postpartum women who agree to participate in the study.
Descripción general del estudio
Tipo de estudio
Intervencionista
Inscripción (Estimado)
128
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Estudio Contacto
- Nombre: Yasemin, AYDIN KARTAL, Prof. Dr.
- Número de teléfono: (0216) 777 87 77
- Correo electrónico: yasemin.aydin@sbu.edu.tr
Copia de seguridad de contactos de estudio
- Nombre: Merve N KAYADUMAN, Midwife
- Número de teléfono: (0216) 777 87 77
- Correo electrónico: merve.kydmn@gmail.com
Ubicaciones de estudio
-
-
-
Istanbul, Turquía (Türkiye)
- Sağlık Bilimleri Üniversitesi, İstanbul,
-
Contacto:
- Merve N KAYADUMAN, Midwife
- Número de teléfono: (0216) 777 87 77
- Correo electrónico: merve.kydmn@gmail.com
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Niño
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Sí
Descripción
Inclusion Criteria:
- - Being primiparous
- Having a full-term, singleton birth
- Having a healthy newborn
- Having a spontaneous vaginal birth
Exclusion Criteria:
- Being multiparous (having given birth more than once)
- Having given birth preterm or postterm
- Having a mother or newborn with health problems
- Having had a multiple pregnancy
- Having had a cesarean section
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Otro
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Doble
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: intervention group
Mothers in the intervention group will receive breastfeeding training using the Pecha Kucha presentation technique at the first hour postpartum
|
Training will be provided using training material consisting of 20 slides, each lasting 20 seconds, prepared using the 'Pecha Kucha' technique, for a total duration of 6 minutes and 20 seconds.
|
|
Sin intervención: control group
Standard breastfeeding education, as part of the routine postpartum care practices of the Ministry of Health, will be given to the puerperal women in the control group at the first hour postpartum.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
introductory information form
Periodo de tiempo: 10 minitus
|
This form, created by researchers based on literature, includes questions about the participants' age, high school graduation, their self-sufficiency against disasters, etc.
|
10 minitus
|
|
Breastfeeding Self-Efficacy Scale
Periodo de tiempo: 10 minutes
|
The Breastfeeding Self-Efficacy Scale was developed by the National Institutes of Health (NIH) to assess mothers' breastfeeding self-efficacy levels.
The initial form consisted of 33 items.
In 2003, the scale was shortened to a 14-item version.Dennis recommends using the short form.
The Breastfeeding Self-Efficacy Short Form Scale is a 5-point Likert-type scale (1 = Not at all confident and 5 = Always confident).
The lowest possible score is 14, and the highest is 70.
As the score increases, breastfeeding self-efficacy also increases.
The validity and reliability of the scale in Turkey were conducted by Aluş Tokat, Okumus, and Dennis (2010).
The scale is a 5-point Likert-type scale, with scores ranging from Not at all confident (1 point) to Always confident (5 points).
The minimum possible score is 14, and the maximum score is 70.
There is no cut-off point for the scale.
A higher score indicates higher breastfeeding self-efficacy.
The Cronbach's alpha for the scale was found to be0.87
|
10 minutes
|
|
Latch Breastfeeding Diagnostic and Assessment Scale
Periodo de tiempo: 10 minutes
|
The LATCH Breastfeeding Diagnostic Measurement Tool was developed by Jensen and colleagues (1994).
LATCH is a diagnostic tool created by simulating the Apgar scoring system in terms of its scoring method.
It is a quick and easy scale to evaluate (Jensen, Wallace 1994).
The Turkish validation of the tool was conducted by Demirhan in 1997, Koyun in 2001, and Yenal and Okumuş in 2003, and it was recommended as a reliable tool.
The lowest score obtained from the scale is 0, and the highest is 10.
A higher score indicates breastfeeding success.
The Cronbach's alpha value of the LATCH Breastfeeding Diagnostic Measurement Tool was found to be 0.95 by Yenal and Okumuş.
|
10 minutes
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Estimado)
13 de junio de 2026
Finalización primaria (Estimado)
1 de julio de 2026
Finalización del estudio (Estimado)
1 de diciembre de 2026
Fechas de registro del estudio
Enviado por primera vez
13 de junio de 2026
Primero enviado que cumplió con los criterios de control de calidad
13 de junio de 2026
Publicado por primera vez (Actual)
18 de junio de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
18 de junio de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
13 de junio de 2026
Última verificación
1 de junio de 2026
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- SBU-AYDINKARTAL-KAYADUMAN
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
NO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Pecha Kuka
-
Firat UniversityTerminadoCuidados paliativos | Pecha KukaPavo